In the News

Precision Medicine: The Future Starts Now

Welcome to the brave new world of precision medicine, in which the diseases themselves can point to a treatment and even a cure.

With leading-edge research and groundbreaking partnerships, City of Hope stands in the precision medicine vanguard.

Cancer 2016: More powerful treatments, more individualized approaches

Precision medicine, immunotherapy, clinical trials … 2016 will be a year of many changes in science and medicine – and nowhere is this more obvious than in the field of cancer research.

Breast cancer 2016: Dramatic advances create revolution in treatment

The evolution of breast cancer treatment has become a revolution thanks to precision medicine, improved screening and a move to more refined surgical techniques. This momentum will continue in 2016 as advances such as immunotherapy, nipple-sparing surgery and gene therapy continue to transform the field.

Leukemia 2016: More treatments will target leukemia by type

Leukemia is not one disease, but many individual diseases – and in 2016, treatments will increasingly target the specific types.

Precision medicine: What it means now. What it means for the future

Welcome to the brave new world of precision medicine, in which the diseases themselves can point to a treatment and even a cure. What was once dismissed as futuristic has now become reality for some cancer patients, and with leading-edge research and groundbreaking partnerships, City of Hope stands in the precision medicine vanguard.

ASCO 2016: Where cancer breakthroughs happen

Sumanta Kumar Pal, M.D., offers insights into ASCO 2016. Here, he has distilled some of the main themes at this year's conference such as the Cancer Moonshot Program, and personalized and precision medicine.

ADA 2016: Unlocking precision medicine to treat diabetes

The American Diabetes Association's 76th Scientific Sessions — the largest annual of gathering on diabetes research, treatment and care — got underway June 10 in New Orleans.

Precision medicine isn't science fiction; access shouldn't be either

If you haven’t heard the term “precision medicine,” you will. If you don’t have an opinion about access to it, you will. Precision medicine is expected to grow by leaps and bounds with the recently announced Precision Medicine Initiative.

Lymphoma expert Larry Kwak speaks on precision medicine's great promise

A cancer cell grows uncontrollably and undergoes as many as 200 mutations. The challenge for cancer researchers is figuring out which changes are causing the cancer cell to grow and which are inconsequential.

ORIEN network will accelerate data exchange – and new cancer therapies

With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments.

Cancer Insights: The dawn of precision medicine for cancer

"Tonight, I'm launching a new precision medicine initiative to bring us closer to curing diseases like cancer." These were the words of President Barack Obama on Jan. 20, 2015, during his State of the Union address .

Precision medicine: It's here – now to make it a norm, not an exception

Precision medicine holds promise – one that doctors, especially cancer specialists, can agree. But this sophisticated approach to treatment, which incorporates knowledge about a person’s genetic profile, environment and lifestyle, isn’t yet standard for all cancers.


NCI-MATCH: Trial focuses on mutations for rare cancers, not tumor site

Precision medicine is becoming a reality for cancers with genetic mutations that are practically household names, such as those behind some breast cancers and lung cancers. A new multicenter trial focuses on providing precision treatments for rare cancers based on genetics, not tumor site.